Abstract:Rumen-protected choline (RPC) supplementation in the periparturient period has in some instances prevented and alleviated fatty liver disease in dairy cows. Mechanistically, however, it is unclear how choline prevents the accumulation of lipid droplets (LD) in liver cells. In this study, primary liver cells isolated from liver tissue obtained via puncture biopsy from 3 nonpregnant midlactation multiparous Holstein cows (∼160 d postpartum) were used. Analyses of LD via oil red O staining, protein abundance via Western blotting, and phospholipid content and composition measured by thin-layer chromatography and HPLC/MC were performed in liver cells cultured in choline-deficient medium containing 150 μmol/L linoleic acid for 24 h. In a subsequent experiment, lipophagy was assessed in liver cells cultured with 30, 60 or 90 µmol/L choline-chloride. All data were analyzed statistically using SPSS 20.0 via t-tests or one-way ANOVA. Compared with liver cells cultured in DMEM medium alone, choline deficiency increased the average diameter of LD (1.59 µm vs. 2.10 µm), decreased the proportion of small LD (<2 µm) from 75.3% to 56.6%, and increased the proportion of large LD (>4 µm) from 5.6% to 15.0%. In addition, the speed of LD fusion was enhanced by the absence of choline. Among phospholipid species, the phosphatidylcholine (PC) content of liver cells decreased by 34.5%. Seventeen species of PC [PC (18:2_22:6), PC (15:0_16:1), PC (14:0_20:4), etc] and 6 species of LPC [LPC (15:0/0:0)], PC (22:2/0:0), LPC (20:2/0:0), etc] were decreased, while PC (14:1_16:1) and LPC (0:0/20:1) were increased. Choline deficiency increased the Triglyceride (TAG) content (0.57 μmol/mg vs. 0.39 μmol/mg) in liver cells and increased the protein abundance of sterol regulatory element binding protein 1 (SREBP1), sterol regulatory element binding protein cleavage activation protein (SCAP), and fatty acid synthase (FASN) by 23.5%, 17%, and 36.1%, respectively. Upon re-supplementation with choline, the phenotype of LD (TAG content, size, proportion, and phospholipid profile) was reversed, and the ratio of autophagy marker LC3II/LC3I protein was significantly upregulated in a dose-dependent manner. Overall, at least in vitro in midlactation cows, these data demonstrated that PC synthesis is necessary for normal LD formation and both rely on choline availability. According to the limitation of the source of liver cells used, further work should be conducted to ascertain that these effects are applicable to liver cells from postpartum cows, the physiological stage where the use of rumen-protected choline has been implemented for the prevention and treatment of fatty liver.

The Effects of Choline on Hepatic Lipid Metabolism, Mitochondrial Function and Antioxidative Status in Human Hepatic C3A Cells Exposed to Excessive Energy Substrates

Dietary choline increases brown adipose tissue activation markers and improves cholesterol metabolism in female APOE*3-Leiden.CETP mice

Effects of Choline on DNA Methylation and Macronutrient Metabolic Gene Expression in in Vitro Models of Hyperglycemia

Effects of Choline and Glucose on Macronutrient Metabolic Gene Expression in Hepg2 and Bewo Cells

Metabolomic Profiling Can Predict Which Humans Will Develop Liver Dysfunction when Deprived of Dietary Choline

Dietary Choline Supplementation Attenuates High-Fat-Diet-Induced Hepatocellular Carcinoma in Mice

Choline and Methionine Regulate Lipid Metabolism Via the AMPK Signaling Pathway in Hepatocytes Exposed to High Concentrations of Nonesterified Fatty Acids

Choline, Its Potential Role in Nonalcoholic Fatty Liver Disease, and the Case for Human and Bacterial Genes

Phosphatidylcholine Protects Against the Hepatotoxicity of Acrylamide Via Maintaining Metabolic Homeostasis of Glutathione and Glycerophospholipid

Dietary Choline Mitigates High-Fat Diet-Impaired Chylomicrons Assembly Via UPRer Modulated by Perk DNA Methylation

Choline Ameliorates Tris (2-Chloroisopropyl) Phosphate-Induced Hepatocellular Carcinoma Metastasis by Inhibiting ROS/Nrf2/Keap1-mediated Autophagy

Dietary Choline Alleviates High-Fat Diet-Induced Hepatic Lipid Dysregulation via UPRmt Modulated by SIRT3-Mediated mtHSP70 Deacetylation

Betaine Supplement Alleviates Hepatic Triglyceride Accumulation of Apolipoprotein E Deficient Mice Via Reducing Methylation of Peroxisomal Proliferator-Activated Receptor Alpha Promoter

Effects of Dietary Choline, Betaine, and L-carnitine on the Generation of Trimethylamine-N-oxide in Healthy Mice.

Fatty acid-induced lipotoxicity inhibits choline metabolism independent of ER stress in mouse primary hepatocytes

The impact of choline availability on muscle lipid metabolism

Choline Ameliorates Cardiac Hypertrophy by Regulating Metabolic Remodelling and UPRmt Through SIRT3-AMPK Pathway

Effects of choline on hepatic antioxidant status, ultrastructure and innate immunity in blunt snout bream (Megalobrama amblycephala) fed high-fat diet

Effects of choline deficiency and supplementation on lipid droplet accumulation in bovine primary liver cells in vitro.

The Interplay Between Dietary Choline and Cardiometabolic Disorders: A Review of Current Evidence

Hepatotoxicity and Endothelial Dysfunction Induced by High Choline Diet and the Protective Effects of Phloretin in Mice